Literature DB >> 18703097

Genome cyclization as strategy for flavivirus RNA replication.

Sergio M Villordo1, Andrea V Gamarnik.   

Abstract

Long-range and local RNA-RNA contacts in viral RNA genomes result in tertiary structures that modulate the function of enhancers, promoters, and silencers during translation, RNA replication, and encapsidation. In the case of flaviviruses, the presence of inverted complementary sequences at the 5' and 3' ends of the genome mediate long-range RNA interactions and RNA cyclization. The circular conformation of flavivirus genomes was demonstrated to be essential for RNA amplification. New ideas about the mechanisms by which circular genomes participate in flavivirus replication have emerged in the last few years. Here, we will describe the latest information about cis-acting elements involved in flavivirus genome cyclization, RNA promoter elements required for viral polymerase recognition, and how these elements together coordinate viral RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703097      PMCID: PMC5440119          DOI: 10.1016/j.virusres.2008.07.016

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  68 in total

1.  Architecture of the flaviviral replication complex. Protease, nuclease, and detergents reveal encasement within double-layered membrane compartments.

Authors:  Pradeep Devappa Uchil; Vijaya Satchidanandam
Journal:  J Biol Chem       Date:  2003-04-16       Impact factor: 5.157

2.  Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus.

Authors:  Steven L Allison; Yizhi J Tao; Gabriel O'Riordain; Christian W Mandl; Stephen C Harrison; Franz X Heinz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  La protein binds to NS5 and NS3 and to the 5' and 3' ends of Dengue 4 virus RNA.

Authors:  Beatriz María García-Montalvo; Fernando Medina; Rosa M del Angel
Journal:  Virus Res       Date:  2004-06-15       Impact factor: 3.303

4.  Conserved RNA secondary structures in Flaviviridae genomes.

Authors:  Caroline Thurner; Christina Witwer; Ivo L Hofacker; Peter F Stadler
Journal:  J Gen Virol       Date:  2004-05       Impact factor: 3.891

5.  Phylogeny of the genus Flavivirus.

Authors:  G Kuno; G J Chang; K R Tsuchiya; N Karabatsos; C B Cropp
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Dissociation of NS5 from cell fractions containing West Nile virus-specific polymerase activity.

Authors:  J B Grun; M A Brinton
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

7.  Mov34 protein from mouse brain interacts with the 3' noncoding region of Japanese encephalitis virus.

Authors:  M Ta; S Vrati
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Nuclear localization of flavivirus RNA synthesis in infected cells.

Authors:  Pradeep Devappa Uchil; Anil V A Kumar; Vijaya Satchidanandam
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5.

Authors:  Hélène Malet; Marie-Pierre Egloff; Barbara Selisko; Rebecca E Butcher; Peter J Wright; Michael Roberts; Arnaud Gruez; Gerlind Sulzenbacher; Clemens Vonrhein; Gérard Bricogne; Jason M Mackenzie; Alexander A Khromykh; Andrew D Davidson; Bruno Canard
Journal:  J Biol Chem       Date:  2007-02-07       Impact factor: 5.157

10.  Synthesis and localization of Japanese encephalitis virus RNAs in the infected cells.

Authors:  T Takegami; S Hotta
Journal:  Microbiol Immunol       Date:  1990       Impact factor: 1.955

View more
  89 in total

1.  Uncoupling cis-Acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation.

Authors:  Marcelo M Samsa; Juan A Mondotte; Julio J Caramelo; Andrea V Gamarnik
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Composition of the sequence downstream of the dengue virus 5' cyclization sequence (dCS) affects viral RNA replication.

Authors:  Peter Friebe; José Peña; Marie O F Pohl; Eva Harris
Journal:  Virology       Date:  2011-12-01       Impact factor: 3.616

3.  The 5' and 3' downstream AUG region elements are required for mosquito-borne flavivirus RNA replication.

Authors:  Peter Friebe; Pei-Yong Shi; Eva Harris
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  Building p53.

Authors:  Tamara Terzian; Guillermina Lozano
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

5.  A balance between circular and linear forms of the dengue virus genome is crucial for viral replication.

Authors:  Sergio M Villordo; Diego E Alvarez; Andrea V Gamarnik
Journal:  RNA       Date:  2010-10-27       Impact factor: 4.942

Review 6.  Flavivirus RNA synthesis in vitro.

Authors:  Radhakrishnan Padmanabhan; Ratree Takhampunya; Tadahisa Teramoto; Kyung H Choi
Journal:  Methods       Date:  2015-08-10       Impact factor: 3.608

7.  RNA sequences and structures required for the recruitment and activity of the dengue virus polymerase.

Authors:  Claudia V Filomatori; Nestor G Iglesias; Sergio M Villordo; Diego E Alvarez; Andrea V Gamarnik
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

8.  Interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication.

Authors:  Peter Friebe; Eva Harris
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

9.  Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells.

Authors:  Esther Schnettler; Mark G Sterken; Jason Y Leung; Stefan W Metz; Corinne Geertsema; Rob W Goldbach; Just M Vlak; Alain Kohl; Alexander A Khromykh; Gorben P Pijlman
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 10.  AUF1 regulation of coding and noncoding RNA.

Authors:  Elizabeth J F White; Aerielle E Matsangos; Gerald M Wilson
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-09-13       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.